{"id":"W1990481620","doi":"10.1097/01.mou.0000175572.46986.2c","title":"Antisense oligonucleotide therapy in the management of bladder cancer","year":2005,"lang":"en","type":"review","venue":"Current Opinion in Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Cystoscopy; Antisense therapy; Bladder cancer; Oligonucleotide; Cancer; In vivo; Genetic enhancement; Cancer research; Urinary system; Internal medicine; Biology; Locked nucleic acid; Gene; Biotechnology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005442965,0.0008374111,0.001564561,0.001797879,0.0002556993,0.0006293005,0.0007629316,0.0009907235,0.003868559],"category_scores_gemma":[0.0005620921,0.0001750659,0.0004103315,0.001554179,0.0003670897,0.0007964609,0.0003926643,0.001111306,0.002938984],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004713458,"about_ca_system_score_gemma":0.0006700803,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007469463,"about_ca_topic_score_gemma":0.001553331,"domain_scores_codex":[0.9998218,0.00004336908,0.0000257866,0.00002489503,0.00006944053,0.00001469691],"domain_scores_gemma":[0.9997788,0.00008766301,0.00004644248,0.00000511592,0.00005688922,0.00002507686],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008049751,0.00009121119,0.0002125839,0.01382725,0.00008644791,0.0004889916,0.00005092223,0.0004554931,0.003496646,0.00136601,0.02039684,0.9594472],"study_design_scores_gemma":[0.0000461128,0.0003049061,0.00150416,0.005109331,0.0001965331,0.005671028,0.0000987914,0.0002007972,0.001801586,0.001230818,0.9838103,0.0000257744],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001851942,0.9983537,0.0001639142,0.0001965877,0.0002881026,0.00000659364,0.000008090756,0.000007217703,0.000790667],"genre_scores_gemma":[0.0009038742,0.9977012,0.0002839371,0.0001878995,0.0003313507,0.000009121304,0.00001961157,0.000001723309,0.0005612703],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003868559,"threshold_uncertainty_score":0.0129416,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1447929501662539,"score_gpt":0.4494625595887894,"score_spread":0.3046696094225356,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}